Bile duct cancer, also known as cholangiocarcinoma, is a rare type of cancer that forms in the bile duct. The bile duct is a thin tube that carries bile from the liver and gallbladder to the small intestine. Bile helps with digestion by helping to break down fats. Signs and symptoms of bile duct cancer may include jaundice, itching, abdominal pain, weight loss, and clay-colored stool. Bile duct cancer is diagnosed through various tests and scans such as CT scan, MRI, endoscopic ultrasound, and biopsy. Treatment options include surgery, radiation therapy, chemotherapy, liver transplantation, etc.

The Global Bile Duct Cancer Market Size is estimated to be valued at US$ 235.9 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising incidence of bile duct cancer cases has been a key factor driving the growth of the bile duct cancer market. According to the statistics provided by Pancreatic Cancer Action Network, around 8,000 new cases of bile duct cancer are diagnosed each year in the United States. The risk of getting bile duct cancer increases with age and is most commonly seen in older adults over age 70. Other factors such as obesity, primary sclerosing cholangitis, liver fluke infection, and genetic conditions are also contributing to the increasing bile duct cancer prevalence globally. With the continued rise in associated risk factors, the demand for effective bile duct cancer treatment and diagnostic options is expected to rise significantly during the forecast period. This will hence propel the growth of the global bile duct cancer market.

Explore More Related Article On This Topic: https://www.newsanalyticspro.com/bile-duct-cancer-market-size-propelled-by-rising-cases-of-bile-duct-cancer/

https://careersplay.com/artificial-intelligence-in-genomics-unlocking-the-mysteries-of-human-dna